Fig. 1From: Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft modelSchematic illustration of allograft E.7 tumor modelSix-week-old of female C57BL/6 mice were randomly assigned into 5 groups: 1× PBS, E.7, E.7 + anti-PD-L1 antibody (α-mPD-L1), E.7 + NKDC, and E.7 + α-mPD-L1 + NKDC, and administrated with α-mPD-L1, NKDCs, both, or PBS, respectively, for 28 daysBack to article page